Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jee-Hyun
Jee-Hyun Cho, Daejeon KR
| Patent application number | Description | Published |
|---|---|---|
| 20110165086 | IRON OXIDE NANOPARTICLES AS MRI CONTRAST AGENTS AND THEIR PREPARING METHOD - Iron oxide nano contrast agents for Magnetic Resonance Imaging which have superior T | 07-07-2011 |
Jee-Hyun Kim, Seongnam-Si KR
| Patent application number | Description | Published |
|---|---|---|
| 20110158123 | METHOD AND APPARATUS FOR TRANSMITTING/RECEIVING CHANNEL QUALITY INFORMATION IN A COMMUNICATION SYSTEM USING AN ORTHOGONAL FREQUENCY DIVISION MULTIPLEXING SCHEME - A method and Mobile Subscriber Station (MSS) are provided for transmitting Channel Quality Information (CQI) in a wireless communication system using an Orthogonal Frequency Division Multiple Access (OFDMA) scheme. A Carrier to Interference and Noise Ratio (CINR) of at least two bands are measured; each of the at least two bands including a plurality of adjacent subcarriers for a band Adaptive Modulation and Coding (AMC) operation. A Report Response (REP-RSP) message including first information related to the measured CINR is sent. Second information related to a differential CINR of the at least two bands is sent via a Channel Quality Information Channel (CQICH). | 06-30-2011 |
Jee-Hyun Park, Daejeon KR
| Patent application number | Description | Published |
|---|---|---|
| 20100138928 | APPARATUS AND METHOD FOR SHARING CONTENT BETWEEN DEVICES BY USING DOMAIN DRM - An apparatus for sharing content between devices by using a domain digital rights management (DRM) includes: a domain management unit for performing management of a domain within a specific area and registration of users and user devices; a user management unit for managing information about the users of the domain registered by the domain management unit; and a device management unit for managing domain clients of the domain registered by the domain management unit. The apparatus further includes a DRM management unit that has DRM information that supports the domain created through the domain management unit and update information about each DRM, and relays such that DRM content stored in each domain client is converted into domain DRM content and domain DRM license. | 06-03-2010 |
| 20100161781 | APPARATUS AND METHOD FOR DIGITAL HOME DOMAIN MANAGEMENT - An apparatus for digital home domain management includes a home domain server which manages in one user domain all user terminals within a home group and provides each user terminal with a domain license in contents; and a DRM coupler which provides the contents and domain licenses converted to conform to a DRM type loaded in user terminals if contents sharing is requested among user terminals loaded with different DRMs within the home group. | 06-24-2010 |
| 20100250439 | APPARATUS AND METHOD FOR PROTECTING CONTENTS STREAMED THROUGH RE-TRANSMISSION - An apparatus for protecting contents streamed through re-transmission, includes a content service site for servicing a content, managing end user and re-sender re-transmitting the content streamed from the content service site to another user, and issuing and managing a re-transmission license and a content license. The end user pays a charge to the content service site, receives an issued license from the content service site, and uses the content received from the re-sender through re-transmission. | 09-30-2010 |
| 20100329639 | APPARATUS AND METHOD FOR PROTECTING COPYRIGHT FOR MOTION PICTURE AND RECORD MEDIUM - Provided are an apparatus and method for processing motion picture and a record medium, which decompose a motion picture into unit frames and insert copyright information into the unit frames, enabling to determine the infringement of copyright when the motion picture is illegally circulated. The apparatus includes a processing unit, a merging unit and an output unit. The processing unit decomposes a motion picture into a plurality of unit frames, and generates a main frame, a sub-frame including copyright information for the motion picture and a degree frame which is paired with the sub-frame, based on the unit frames. The merging unit merges the sub-frame into the main frame according to a degree of mergence of the degree frame. The output unit continuously outputs the merged frames in time order. | 12-30-2010 |
| 20110029768 | METHOD FOR TRANSMITTING CONTENTS FOR CONTENTS MANAGEMENT TECHNOLOGY INTERWORKING, AND RECORDING MEDIUM FOR STORING PROGRAM THEREOF - A DRM technique interoperability system includes an exporter and an importer. The exporter cancels the DRM technique from the contents to which the DRM technique of a DRM device is applied to generate a contents stream, generates a plurality of packets from the contents stream, and transmits the packets to the importer. The importer receives a plurality of packets from the exporter, generates a contents stream from the plurality of packets, applies a DRM technique of a second DRM device to the contents stream, and provides it to the second DRM device. | 02-03-2011 |
Jee-Hyun Park, Yongin-Si KR
| Patent application number | Description | Published |
|---|---|---|
| 20090286369 | Method of manufacturing a semiconductor device - In a method of manufacturing a semiconductor device, a tunnel insulation layer is formed on a substrate. A charge trapping layer is formed on the tunnel insulation layer. A protection layer pattern or a mold is formed on the charge trapping layer. Charge trapping layer patterns are formed on the tunnel insulation layer by etching the charge trapping layer using the protection layer pattern or the mold. The charge trapping layer patterns may be spaced apart from each other. Blocking layers are formed on the charge trapping layer patterns, respectively. A gate electrode is formed on the blocking layers and the tunnel insulation layer using the protection layer pattern or the mold. | 11-19-2009 |
Jee-Hyun Seo, Deajeon-Shi KR
| Patent application number | Description | Published |
|---|---|---|
| 20080306010 | VACCINE COMPOSITION CONTAINING IRRADIATED OVALBUMIN FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE - The present invention relates to a vaccine composition for the prevention and treatment of allergic disease comprising irradiated ovalbumin as an effective ingredient, more precisely a method for preparing an immunogen of a vaccine for the prevention and treatment of allergic disease using the irradiated ovalbumin which is separated and purified from the albumen of an egg, a vaccine composition for the prevention and treatment of allergic disease comprising the irradiated ovalbumin as an effective ingredient, and a method for the prevention and treatment of allergic disease using the vaccine comprising the irradiated ovalbumin. In the mouse vaccinated with the irradiated ovalbumin, humoral and cell mediated immune responses were both reduced, suggesting that allergic reaction was inhibited. Thus, the composition of the present invention can be effectively used as a vaccine for the prevention and treatment of allergic disease. | 12-11-2008 |
Jee-Hyun Shin, Seoul KR
| Patent application number | Description | Published |
|---|---|---|
| 20100173915 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC HEART FAILURE COMPRISING PYRAZOLOPYRIMIDINONE DERIVATIVE COMPOUND - Disclosed herein is a therapeutic agent for chronic heart failure comprising, as an effective ingredient, 5-[2-propyloxy-5-(1-methyl-2-pyrrolidinyl-ethylamidosulfonyl)phenyl]-1-methyl-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidine-7-one. The compound inhibits phosphodiesterase-5 (PDE-5), which catalyzes the intracellular degradation of cyclic guanosine monophosphatase (cGMP), thereby mitigating several signs of chronic heart failure, that is, thereby preventing left ventricular dilatation, decreasing ventricular wall thinning, lowering elevated cardiac and circulating levels of atrial natriuretic peptide (ANP), and inhibiting ventricular fibrosis. Also, the compound has advantages in that it reaches the maximal plasma level in a short time, has an in vivo half-life longer than conventional PDE-5 inhibitors, allowing decreased administration frequency, and has fewer side effects, thus ensuring safety. Thus, the compound is useful as a therapeutic agent for chronic heart failure. | 07-08-2010 |